ITIH4 and cervical cancer: Our previous accumulated studies have demonstrated the overexpression of a 35 kDa ITIH4 fragment selectively in cancers associated with elevated oestrogen levels, including cancers of the breast, endometrium, ovary and prostate but not in nasopharyngeal carcinoma, osteosarcoma and cervical cancer.